NCT06026475

Brief Summary

Enhanced recovery after surgery (ERAS) protocols are multimodal perioperative care pathways designed to achieve early recovery and reducing postoperative morbidity after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery .The key elements of ERAS protocols include preoperative counselling, optimization of nutrition, standardized analgesic and anesthetic regimens , goal directed fluid therapy early mobilization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 13, 2023

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

July 29, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 7, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 19, 2024

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2024

Completed
Last Updated

March 5, 2024

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

July 29, 2023

Last Update Submit

March 3, 2024

Conditions

Keywords

Goal Directed Fluid TherapyStroke volume variationEnhanced recovery after surgery

Outcome Measures

Primary Outcomes (2)

  • Duration of ICU stay

    Time of shifting of patients in both group to the ward in hours.

    upto 5 days .

  • Postoperative serum Lactate levels mmol/L

    Serum lactate levels will be measured in the SICU

    upto 48 hours

Secondary Outcomes (1)

  • Serum Creatinine levels mg/dL.

    Upto 48 hours.

Study Arms (2)

Intraoperative Goal Directed Fluid Therapy (GDFT) guided by Stroke Volume Variation (SVV)

ACTIVE COMPARATOR

When SVV values will increase above 11 colloid bolus 200ml will be administered. postbolus change in values of SVV , SV , SVI and CI shall be noted.

Procedure: Goal directed Fluid Therapy

Intraoperative Conventional Fluid Therapy (CFT) guided by Central Venous Pressure (CVP) .

ACTIVE COMPARATOR

When CVP values will decrease below 8 cmsH20 colloid bolus 200ml will be administered .Postbolus change in values shall be noted .

Procedure: Conventional Fluid Therapy

Interventions

Patients will receive fluid during surgery with goal of maintaining SVV below 11

Intraoperative Goal Directed Fluid Therapy (GDFT) guided by Stroke Volume Variation (SVV)

Patients will receive fluid during surgery with goal of maintaining CVP between 8-12 cms H20

Intraoperative Conventional Fluid Therapy (CFT) guided by Central Venous Pressure (CVP) .

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective major open gastrointestinal Oncosurgeries .

You may not qualify if:

  • Patient refusal.
  • Robotic surgery.
  • Laparoscopic surgery.
  • Arrythmias.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anita Kulkarni

New Delhi, Please Select, 110078, India

Location

Related Publications (1)

  • Chong MA, Wang Y, Berbenetz NM, McConachie I. Does goal-directed haemodynamic and fluid therapy improve peri-operative outcomes?: A systematic review and meta-analysis. Eur J Anaesthesiol. 2018 Jul;35(7):469-483. doi: 10.1097/EJA.0000000000000778.

    PMID: 29369117BACKGROUND

Study Officials

  • Anita Kulkarni, MD

    Rajiv Gandhi Cancer Institute and Research Centre , Delhi , India

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participant will be masked about allotment of interventional group either CVP or SVV .
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients in Conventional Group will be given intraoperative fluids guided by CVP Values . Patients in GDFT Group will be given fluids guided by SVV values.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 29, 2023

First Posted

September 7, 2023

Study Start

July 13, 2023

Primary Completion

January 19, 2024

Study Completion

January 30, 2024

Last Updated

March 5, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations